Effectiveness and Tolerability of a Moderate Dose of Tapentadol Prolonged Release for Managing Severe, Chronic Low Back Pain with a Neuropathic Component: An Open-label Continuation Arm of a Randomized Phase 3b Study (Q39208211)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 April 2014
edit
Language Label Description Also known as
English
Effectiveness and Tolerability of a Moderate Dose of Tapentadol Prolonged Release for Managing Severe, Chronic Low Back Pain with a Neuropathic Component: An Open-label Continuation Arm of a Randomized Phase 3b Study
scientific article published on 18 April 2014

    Statements

    Effectiveness and Tolerability of a Moderate Dose of Tapentadol Prolonged Release for Managing Severe, Chronic Low Back Pain with a Neuropathic Component: An Open-label Continuation Arm of a Randomized Phase 3b Study (English)
    Ralf Baron
    Uwe Kern
    Matthias Müller
    Cecile Dubois
    Dietmar Falke
    Ilona Steigerwald
    18 April 2014
    471-486

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit